一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

Sargramostim

Sargramostim Struktur
123774-72-1
CAS-Nr.
123774-72-1
Englisch Name:
Sargramostim
Synonyma:
r-HuGM-CSF;Sargramostim;Sargramostim USP/EP/BP;Recombinant Human Granulocyte Macrophage-Colony Stimulating Factor;Recombinant Protein (Human Granulocyte-Macrophage Colony StimulatingFactor)
CBNumber:
CB3874901
Summenformel:
Molgewicht:
0
MOL-Datei:
Mol file

Sargramostim Eigenschaften

Sicherheit
  • Risiko- und Sicherheitserkl?rung
  • Gefahreninformationscode (GHS)
HS Code  3504009000
Bildanzeige (GHS) Exclamation Mark (GHS07)
Alarmwort Warnung
Gefahrenhinweise
Code Gefahrenhinweise Gefahrenklasse Abteilung Alarmwort Symbol P-Code
H315 Verursacht Hautreizungen. Hautreizung Kategorie 2 Warnung P264, P280, P302+P352, P321,P332+P313, P362
H319 Verursacht schwere Augenreizung. Schwere Augenreizung Kategorie 2 Warnung P264, P280, P305+P351+P338,P337+P313P
H335 Kann die Atemwege reizen. Spezifische Zielorgan-Toxizit?t (einmalige Exposition) Kategorie 3 (Atemwegsreizung) Warnung
Sicherheit
P261 Einatmen von Staub vermeiden.
P271 Nur im Freien oder in gut belüfteten R?umen verwenden.
P280 Schutzhandschuhe/Schutzkleidung/Augenschutz tragen.

Sargramostim Chemische Eigenschaften,Einsatz,Produktion Methoden

Beschreibung

Sargramostim, a recombinant DNA product, is a granulocyte macrophage colony stimulating factor (GM-CSF) indicated for the treatment of cancer patients after autologous bone marrow transplants. It stimulates immature cells to develop into granulocytes and macrophages and can also switch on mature granulocytes and macrophages.Other indications include improved bone m m w recovery in non-Hodgkins lymphoma and acute lymphoblastic leukemia.

Verwenden

Antineutropenic; hematopoietic stimulant.

Indications

Sargramostim (GM-CSF, Leukine, Prokine) is a human recombinant granulocyte and macrophage colony– stimulating factor that stimulates the production and potentiates the function of both granulocytes and macrophages from hematopoietic progenitor cells. It is used to accelerate bone marrow repopulation after high-dose chemotherapy, radiation therapy, and bone marrow transplantation. Adverse effects associated with sargramostim use include bone pain (similar to that of filgrastim), fatigue, fevers, skin rash, malaise, and fluid retention.

Allgemeine Beschreibung

Sargramostim, rGM-CSF (Leukine), isa glycoprotein commercially produced in genetically engineeredyeast cells. Its polypeptide chain contains 127 aminoacids. It differs from the natural hormone by substitution ofleucine at position 23 and variations in the glycosylation.94Sargramostim is a lineage-nonspecific hematopoietic factor,because it promotes the proliferation and maturation ofgranulocytes (neutrophils and eosinophils) and monocytes(macrophages and megakaryocytes).
The primary indication for sargramostim is in myeloidengraftment following autologous bone marrow transplantationand hematopoietic stem cell transplantation. Handling,storage precautions, and adverse effects are similar to thosefor filgrastim.

Clinical Use

Sargramostim binds to specific receptors on target cellsand induces proliferation, activation, and maturation.Administration to patients causes a dose-related increase inthe peripheral white blood cell count. Unlike G-CSF, GMCSFis a multilineage hematopoietic growth factor that inducespartially committed progenitor cells to proliferate anddifferentiate along the granulocyte and the macrophage pathways.It also enhances the function of mature granulocytesand macrophages/monocytes. GM-CSF increases the chemotactic,antifungal, and antiparasitic activities of granulocytesand monocytes. It also increases the cytotoxicity of monocytestoward neoplastic cell lines and activates polymorphonuclearleukocytes to inhibit the growth of tumor cells.
Sargramostim is used to reconstitute the myeloid tissueafter autologous bone marrow transplant and followingchemotherapy in acute myelogenous leukemia. The preparationdecreases the incidence of infection, decreases the numberof days that antibiotics are required, and decreases theduration of hospital stays.

Sargramostim Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


Sargramostim Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 18)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Dideu Industries Group Limited
+86-29-89586680 +86-15129568250
1026@dideu.com China 20581 58
Beijing HuaMeiHuLiBiological Chemical 010-56205725
waley188@sohu.com China 12335 58
Sangon Biotech (Shanghai) Co.,Ltd. 400-821-026
Sales@sangon.com China 6813 58
BBI Solutions +1 207-517-0284 13121892008
BBIname@qq.com China 6049 58
Shanghai Zhongyuan Biotechnology Co., Ltd. 13018342990
CHINA 70 58
Guangzhou Chuangwo Biotechnology Co., Ltd 020-37268893
CHINA 717 58
Copyright 2019 ? ChemicalBook. All rights reserved
安顺市| 成都市| 土默特右旗| 桓台县| 修武县| 徐州市| 青冈县| 嵩明县| 张家川| 乳山市| 孟津县| 闻喜县| 呼和浩特市| 柳河县| 黄骅市| 平果县| 永靖县| 双城市| 内乡县| 敦化市| 普洱| 仁怀市| 三台县| 巴林右旗| 嘉义县| 霍林郭勒市| 宣汉县| 从江县| 繁峙县| 互助| 金平| 武威市| 邓州市| 岱山县| 静安区| 平顶山市| 永年县| 科技| 东山县| 顺昌县| 金塔县|